Publication | Closed Access

2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

Breast OncologyOncologyBreast Cancer PatientsCancer ManagementRandomized Phase 3Breast CancerOsteoporosisBone MetastasesCancer TreatmentMedicineRadiation OncologyOrthopaedic Surgery